NCAM1 and neoplasm: In brief, combination therapies involving ICIs and standard chemotherapies increased lymphocytic infiltration in neoplastic tissue in a pro-inflammatory microenvironment, which makes CD56+ and CD3− large granular lymphocytes more reactive against tumor cells [128].